BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND WFDC2, EDDM4, HE4, WAP5, dJ461P17.6 AND Staging
16 results:

  • 1. [
    Chen J; Xu K; Li C; Tian Y; Li L; Wen B; He C; Cai H; He Y
    Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):4064-4076. PubMed ID: 37526694
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The Utility of Preoperative Serum CA125 Combined with he4 to Predict Lymph Node Metastasis in Endometrial cancer.
    Prueksaritanond N; Angsathapon S; Insin P
    Gynecol Obstet Invest; 2023; 88(1):53-60. PubMed ID: 36596280
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Detection of plasma exosomal miRNA-205 as a biomarker for early diagnosis and an adjuvant indicator of ovarian cancer staging.
    Zhu Z; Chen Z; Wang M; Zhang M; Chen Y; Yang X; Zhou C; Liu Y; Hong L; Zhang L
    J Ovarian Res; 2022 Feb; 15(1):27. PubMed ID: 35183243
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Past, Present, and Future of Serum Tumor Markers in Management of ovarian cancer: A Guide for the Radiologist.
    Rao S; Smith DA; Guler E; Kikano EG; Rajdev MA; Yoest JM; Ramaiya NH; Tirumani SH
    Radiographics; 2021 Oct; 41(6):1839-1856. PubMed ID: 34597221
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Application of serum markers in diagnosis and staging of ovarian endometriosis.
    Tang T; Lai H; Huang X; Gu L; Shi H
    J Obstet Gynaecol Res; 2021 Apr; 47(4):1441-1450. PubMed ID: 33448139
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Correlation analysis and clinical significance of CA125, he4, DDI, and FDP in type II epithelial ovarian cancer.
    Qiao L; Chen X; Xi X; Chen X; Zhang P; Dong H; Wu X; Chen X
    Medicine (Baltimore); 2020 Dec; 99(49):e23329. PubMed ID: 33285710
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. he4 and CA125 as preoperative risk stratifiers for lymph node metastasis in endometrioid carcinoma of the endometrium: A retrospective study in a cohort with histological proof of lymph node status.
    O'Toole SA; Huang Y; Norris L; Power Foley M; Shireen R; McDonald S; Kamran W; Ibrahim N; Ward M; Thompson C; Murphy C; D'Arcy T; Farah N; Heron E; O'Leary JJ; Abu Saadeh F; Gleeson N
    Gynecol Oncol; 2021 Feb; 160(2):514-519. PubMed ID: 33213897
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Institutional results of Oncoovarian Dx - a novel algorithm for the preoperative evaluation of adnexal masses.
    Kubelac P; Craciun A; Jalba O; Gheorghe S; Lazar G; Ignat F; Lisencu C; Rancea A; Vlad C; Irimie A; Achimas Cadariu P
    J BUON; 2020; 25(3):1658-1663. PubMed ID: 32862619
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Guideline No. 403: Initial Investigation and Management of Adnexal Masses.
    Salvador S; Scott S; Glanc P; Eiriksson L; Jang JH; Sebastianelli A; Dean E
    J Obstet Gynaecol Can; 2020 Aug; 42(8):1021-1029.e3. PubMed ID: 32736853
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Management of epithelial cancer of the ovary, fallopian tube, and primary peritoneum. Long text of the Joint French Clinical Practice Guidelines issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and endorsed by INCa. Part 1: Diagnostic exploration and staging, surgery, perioperative care, and pathology.
    Lavoue V; Huchon C; Akladios C; Alfonsi P; Bakrin N; Ballester M; Bendifallah S; Bolze PA; Bonnet F; Bourgin C; Chabbert-Buffet N; Collinet P; Courbiere B; De la Motte Rouge T; Devouassoux-Shisheboran M; Falandry C; Ferron G; Fournier L; Gladieff L; Golfier F; Gouy S; Guyon F; Lambaudie E; Leary A; Lecuru F; Lefrere-Belda MA; Leblanc E; Lemoine A; Narducci F; Ouldamer L; Pautier P; Planchamp F; Pouget N; Ray-Coquard I; Rousset-Jablonski C; Senechal-Davin C; Touboul C; Thomassin-Naggara I; Uzan C; You B; Daraï E
    J Gynecol Obstet Hum Reprod; 2019 Jun; 48(6):369-378. PubMed ID: 30936027
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Upregulated expression of serum exosomal miR-375 and miR-1307 enhance the diagnostic power of CA125 for ovarian cancer.
    Su YY; Sun L; Guo ZR; Li JC; Bai TT; Cai XX; Li WH; Zhu YF
    J Ovarian Res; 2019 Jan; 12(1):6. PubMed ID: 30670062
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Value of circulating tumor cells positive for thyroid transcription factor-1 (TTF-1) to predict recurrence and survival rates for endometrial carcinoma.
    Zhang Y; Qu X; Qu PP
    J BUON; 2016; 21(6):1491-1495. PubMed ID: 28039713
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [The importance of he4 in differential diagnosis of endometrial cancer].
    Minář L; Klabenešová I; Jandáková E
    Ceska Gynekol; 2015 Aug; 80(4):256-63. PubMed ID: 26265413
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Prognostic value of human epididymis protein 4 in endometrial cancer and its utility for surgical staging.
    Minar L; Klabenesova I; Jandakova E; Zlamal F; Bienertova-Vasku J
    J Obstet Gynaecol Res; 2015 Oct; 41(10):1644-52. PubMed ID: 26223178
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Ca-125 in diagnosis and monitoring of patients with ovarian cancer].
    Bocheva Y; Bochev P; Ivanov S
    Akush Ginekol (Sofiia); 2015; 54(1):11-7. PubMed ID: 25909124
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Preoperative he4 and ROMA values do not improve the CA125 diagnostic value for borderline tumors of the ovary (BOT) - a study of the TOC Consortium.
    Braicu EI; Van Gorp T; Nassir M; Richter R; Chekerov R; Gasimli K; Timmerman D; Vergote I; Sehouli J
    J Ovarian Res; 2014; 7():49. PubMed ID: 24872845
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.